arrow
L

Laura Richert

Bordeaux University Hospital
H指数:32
被引数:3,303

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

EXPLORING THE FEASIBILITY OF 3D AUGMENTED REALITY IN IMAGE-GUIDED ROBOT-ASSISTED PARTIAL NEPHRECTOMY: INITIAL PROSPECTIVE CLINICAL EXPERIENCE AND OUTCOMES OF 3D AR-IGRAPN (UROCCR 112)

探索图像引导机器人辅助部分肾切除术(3D增强现实-IGRAPN)中3D增强现实的可行性:初步前瞻性临床经验和结果(UROCCR 112)

2026-05-010
PRE
Effect on preoperative anxiety of a personalized three-dimensional kidney model prior to nephron-sparing surgery for renal tumor: study protocol for a randomized controlled trial (Rein 3D Print-Anxiety - UroCCR 113)

个性化三维肾脏模型对肾肿瘤肾部分切除术前焦虑的影响:一项随机对照试验研究方案(Rein 3D Print-Anxiety - UroCCR 113)

2025-04-240
OA
Clinical Trial Protocol for ACCURATE: A CCafU-UroCCR Randomized Trial: Three-dimensional Image-guided Robot-assisted Partial Nephrectomy for Renal Complex Tumor (UroCCR 99)

ACCURATE临床研究方案:一项CCafU-UroCCR随机试验:三维影像引导机器人辅助肾部分切除术治疗肾复杂肿瘤(UroCCR 99)

2025-04-070
PRE
Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial

评估rvsvΔg-zebov-gp和Ad26.ZEBOV,mva-bn-filo埃博拉病毒病疫苗后IgG抗体反应的减弱: 来自PREVAC随机试验的建模研究

2024-12-090
OAAI
Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06)
2024-11-010
OAAI
Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration
2024-07-099
OAAI
Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration
2024-07-095
OAAI
A framework for the definition and interpretation of the use of in interventional trials
2023-11-0115
OAAI
The co-inhibitory receptor TIGIT regulates NK cell function and is upregulated in human intrahepatic CD56bright NK cells
2023-02-099
OAAI
Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C

宿主KIR/hla-c基因型决定了HIV介导的NK细胞库的变化,并与影响hla-c下调的Vpu序列变异有关。

2022-07-158
OAAI
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)
2022-07-0122
OAAI
T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial
2022-06-158
OA
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial
2022-01-1140
OAAI